These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 11809683
1. Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells. Lin J, Jin X, Rothman K, Lin HJ, Tang H, Burke W. Cancer Res; 2002 Jan 15; 62(2):376-80. PubMed ID: 11809683 [Abstract] [Full Text] [Related]
2. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3. Lin J, Tang H, Jin X, Jia G, Hsieh JT. Oncogene; 2002 May 02; 21(19):3082-8. PubMed ID: 12082540 [Abstract] [Full Text] [Related]
3. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R. Int J Oncol; 2004 Mar 02; 24(3):591-608. PubMed ID: 14767544 [Abstract] [Full Text] [Related]
4. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells. Nishimoto A, Yu Y, Lu Z, Mao X, Ren Z, Watowich SS, Mills GB, Liao WS, Chen X, Bast RC, Luo RZ. Cancer Res; 2005 Aug 01; 65(15):6701-10. PubMed ID: 16061651 [Abstract] [Full Text] [Related]
5. Regulation of IL-6 signaling by p53: STAT3- and STAT5-masking in p53-Val135-containing human hepatoma Hep3B cell lines. Rayanade RJ, Ndubuisi MI, Etlinger JD, Sehgal PB. J Immunol; 1998 Jul 01; 161(1):325-34. PubMed ID: 9647240 [Abstract] [Full Text] [Related]
6. Evaluation of potential Stat3-regulated genes in human breast cancer. Hsieh FC, Cheng G, Lin J. Biochem Biophys Res Commun; 2005 Sep 23; 335(2):292-9. PubMed ID: 16081048 [Abstract] [Full Text] [Related]
7. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, Muro-Cacho C, Livingston S, Karras J, Pow-Sang J, Jove R. Cancer Res; 2002 Nov 15; 62(22):6659-66. PubMed ID: 12438264 [Abstract] [Full Text] [Related]
8. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H. Oncogene; 2002 Mar 27; 21(13):2000-8. PubMed ID: 11960372 [Abstract] [Full Text] [Related]
9. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo. Gao L, Zhang L, Hu J, Li F, Shao Y, Zhao D, Kalvakolanu DV, Kopecko DJ, Zhao X, Xu DQ. Clin Cancer Res; 2005 Sep 01; 11(17):6333-41. PubMed ID: 16144938 [Abstract] [Full Text] [Related]
10. Role of Stat3 in regulating p53 expression and function. Niu G, Wright KL, Ma Y, Wright GM, Huang M, Irby R, Briggs J, Karras J, Cress WD, Pardoll D, Jove R, Chen J, Yu H. Mol Cell Biol; 2005 Sep 01; 25(17):7432-40. PubMed ID: 16107692 [Abstract] [Full Text] [Related]
11. Modulation of Janus kinase 2 by p53 in ovarian cancer cells. Reid T, Jin X, Song H, Tang HJ, Reynolds RK, Lin J. Biochem Biophys Res Commun; 2004 Aug 20; 321(2):441-7. PubMed ID: 15358195 [Abstract] [Full Text] [Related]
12. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells. Behera R, Kumar V, Lohite K, Karnik S, Kundu GC. Carcinogenesis; 2010 Feb 20; 31(2):192-200. PubMed ID: 19926637 [Abstract] [Full Text] [Related]
13. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Song L, Turkson J, Karras JG, Jove R, Haura EB. Oncogene; 2003 Jul 03; 22(27):4150-65. PubMed ID: 12833138 [Abstract] [Full Text] [Related]
14. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Zerbini LF, Wang Y, Cho JY, Libermann TA. Cancer Res; 2003 May 01; 63(9):2206-15. PubMed ID: 12727841 [Abstract] [Full Text] [Related]
15. G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis. Jing N, Li Y, Xiong W, Sha W, Jing L, Tweardy DJ. Cancer Res; 2004 Sep 15; 64(18):6603-9. PubMed ID: 15374974 [Abstract] [Full Text] [Related]
16. Complex regulation of signal transducers and activators of transcription 3 activation in normal and malignant keratinocytes. Quadros MR, Peruzzi F, Kari C, Rodeck U. Cancer Res; 2004 Jun 01; 64(11):3934-9. PubMed ID: 15173005 [Abstract] [Full Text] [Related]
17. Retrovirally mediated wild-type p53 restores S-phase modulation without inducing WAF1 mRNA in breast carcinoma cells containing mutant p53. Runnebaum IB, Wang S, Kreienberg R. J Cell Biochem; 1995 Dec 01; 59(4):537-44. PubMed ID: 8749722 [Abstract] [Full Text] [Related]
18. ING1 represses transcription by direct DNA binding and through effects on p53. Kataoka H, Bonnefin P, Vieyra D, Feng X, Hara Y, Miura Y, Joh T, Nakabayashi H, Vaziri H, Harris CC, Riabowol K. Cancer Res; 2003 Sep 15; 63(18):5785-92. PubMed ID: 14522900 [Abstract] [Full Text] [Related]
19. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3. Leslie K, Lang C, Devgan G, Azare J, Berishaj M, Gerald W, Kim YB, Paz K, Darnell JE, Albanese C, Sakamaki T, Pestell R, Bromberg J. Cancer Res; 2006 Mar 01; 66(5):2544-52. PubMed ID: 16510571 [Abstract] [Full Text] [Related]
20. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R. Clin Cancer Res; 2006 Jan 01; 12(1):11-9. PubMed ID: 16397018 [Abstract] [Full Text] [Related] Page: [Next] [New Search]